rs769291842
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001378454.1(ALMS1):c.2221dupA(p.Thr741AsnfsTer2) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000688 in 1,453,110 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001378454.1 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 249020Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135078
GnomAD4 exome AF: 0.00000688 AC: 10AN: 1453110Hom.: 0 Cov.: 40 AF XY: 0.00000692 AC XY: 5AN XY: 722584
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Alstrom syndrome Pathogenic:3
- -
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 552645). This premature translational stop signal has been observed in individual(s) with ALMS1-related conditions (PMID: 28432734). This variant is present in population databases (rs769291842, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Thr742Asnfs*2) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). -
Variant summary: ALMS1 c.2218dupA (p.Thr740AsnfsX2) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 4e-06 in 249020 control chromosomes. c.2218dupA has been reported in the literature in individuals affected with Alstrom Syndrome (e.g. Astuti_2017). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 28432734). ClinVar contains an entry for this variant (Variation ID: 552645). Based on the evidence outlined above, the variant was classified as pathogenic. -
Cardiovascular phenotype Pathogenic:1
The c.2224dupA variant, located in coding exon 8 of the ALMS1 gene, results from a duplication of A at nucleotide position 2224, causing a translational frameshift with a predicted alternate stop codon (p.T742Nfs*2). This variant (also referred to as c.2218dupA) has been reported to co-occur with nonsense variants in the ALMS1 gene in individuals reported to have Alstrom syndrome (Edwards NC et al. Orphanet J Rare Dis, 2015 Jun;10:83; Astuti D et al. Hum Mutat, 2017 07;38:764-777). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at